VCI Global Secures US$51 Million Convertible Note Financing to Expand Sovereign AI Infrastructure and Launch Bitcoin Treasury Reserve 14-08-2025, 18:57

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults 20-12-2025, 03:10

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection 22-10-2024, 19:00